Cresco Labs Files Q1 2025 Financials and News Release
Ticker: CRLBF · Form: 6-K · Filed: May 30, 2025 · CIK: 1832928
| Field | Detail |
|---|---|
| Company | Cresco Labs Inc. (CRLBF) |
| Form Type | 6-K |
| Filed Date | May 30, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: financials, quarterly-report, sec-filing
TL;DR
Cresco Labs dropped Q1 2025 financials & news. Check the numbers.
AI Summary
Cresco Labs Inc. filed a Form 6-K on May 30, 2025, reporting its unaudited condensed interim consolidated financial statements and management discussion for the three months ended March 31, 2025. The filing also includes a news release dated May 30, 2025. Cresco Labs Inc. is incorporated in Delaware and has its principal executive offices in Chicago, IL.
Why It Matters
This filing provides investors with an update on Cresco Labs' financial performance and operational highlights for the first quarter of 2025, offering insights into the company's current standing.
Risk Assessment
Risk Level: medium — Form 6-K filings often contain unaudited financial information and updates that can lead to volatility, especially for companies in regulated industries like cannabis.
Key Players & Entities
- Cresco Labs Inc. (company) — Registrant
- 0001832928-25-000009 (filing_id) — Accession Number
- May 30, 2025 (date) — Filing Date
- March 31, 2025 (date) — Reporting Period End Date
- 600 W. Fulton Street, Suite 800 Chicago, IL 60661 (address) — Principal Executive Offices
FAQ
What specific financial results are detailed in the unaudited condensed interim consolidated financial statements for the three months ended March 31, 2025?
The filing indicates that Exhibit 99.1 contains the 'Unaudited Condensed Interim Consolidated Financial Statements for the three months ended March 31, 2025 and 2024', but the specific figures are not detailed within the provided text.
What is the purpose of the Management Discussion and Analysis included in this filing?
Exhibit 99.2, 'Management Discussion and Analysis of Financial Condition and Results of Operations for the three months ended March 31, 2025 and 2024', is intended to provide context and explanation for the financial statements.
What is the significance of the news release dated May 30, 2025?
The news release, Exhibit 99.3, likely contains important announcements or updates from Cresco Labs Inc. that are relevant to investors and the public.
Under which SEC Act is this Form 6-K filed?
This Form 6-K is filed under the Securities Exchange Act of 1934.
What is Cresco Labs Inc.'s fiscal year end?
Cresco Labs Inc.'s fiscal year ends on December 31.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 30, 2025 regarding Cresco Labs Inc. (CRLBF).